Güney Afrika - İngilizce - South African Health Products Regulatory Authority (SAHPRA)

schering -

Ürdün - İngilizce - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة مستودع الأدوية الأردني - the jordan drugstore co - ethinylestradiol 0.03 mg, drospirenone 3 mg - 0.03 mg, 3 mg

Yeni Zelanda - İngilizce - Medsafe (Medicines Safety Authority)

bayer new zealand limited - drospirenone 3mg (micronised); ethinylestradiol 30ug (present as betadex clathrate, micronised); levomefolate calcium 451ug equivalent to folic acid 400 µg, micronised; levomefolate calcium 451ug equivalent to folic acid 400 µg - tablet - 30µg/ 3mg/ 451µg - active: drospirenone 3mg (micronised) ethinylestradiol 30ug (present as betadex clathrate, micronised) levomefolate calcium 451ug equivalent to folic acid 400 µg, micronised excipient: croscarmellose sodium hyprolose lactose monohydrate magnesium stearate microcrystalline cellulose opadry orange 02f32738 active: levomefolate calcium 451ug equivalent to folic acid 400 µg excipient: croscarmellose sodium hyprolose lactose monohydrate magnesium stearate microcrystalline cellulose opadry pink 02f32737 - yasmin plus is indicated for women who choose to use an oral contraceptive as their method of contraception to raise folate levels for the purpose of reducing the risk of a neural tube defect in a pregnancy conceived while taking the product or shortly after discontinuing the product.